Long-term Outcome of Perioperative Low Cardiac Output Syndrome in Cardiac Surgery: 1-year Results of a Multicenter Randomized Trial
Levosimendan administration does not improve 1-year survival in cardiac surgery patients with perioperative myocardial dysfunction. One-year mortality in these patients is 17%. Six predictive factors for long-term mortality were identified.